Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer - a tool for research and vaccine development

Author: Sanda M.G.   Smith D.C.   Charles L.G.   Hwang C.   Pienta K.J.   Schlom J.   Milenic D.   Panicali D.   Montie J.E.  

Publisher: Elsevier

ISSN: 0090-4295

Source: Urology, Vol.53, Iss.2, 1999-02, pp. : 260-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content